Completed

IH062905Evaluation of the Candela 1064nm:Nd:YAG Laser for Skin Tightening

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

1064 nm Nd:YAG laser

Device
Who is being recruted

Cellulite+1

+ Signs and Symptoms

+ Skin Manifestations

Over 40 Years
+19 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: October 2006
See protocol details

Summary

Principal SponsorUniversity of California, Irvine
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: October 1, 2006

Actual date on which the first participant was enrolled.

The objective of this investigation is to evaluate the effectiveness of a non-ablative treatment for skin laxity by increasing dermatofibrosis of the reticular dermis using the Candela GentleYAG laser. Treatment areas will be limited to the thighs. * The primary objective is to assess the safety and efficacy of the laser for improvement in appearance of cellulite. * The secondary objective is to assess the safety and efficacy of the laser with cooling and the laser without cooling for improvement in appearance of cellulite. This is an open label trial. Treatment will be conducted on either the left or the right thigh, which will be randomly determined. The contra-lateral side will not be treated and will serve as a control. A comparison of baseline photographs (prior to treatments) to photographs taken 1 and 3 months after the completion of treatments will be conducted. Photographic equipment and the protocol for photography will be consistent at each visit. Ultrasound may be taken at baseline and at the follow-up visits to evaluate flatness of cellulite and dermal fibrosis or enlargement of the reticular dermis. The circumference of the area to be treated will be measured with a tape measure, weight/height will be recorded and the Body Mass Index (BMI) will be calculated at baseline and follow-up visits. In addition, skin elasticity may be measured at the treatment areas at baseline and follow-up visits. The photographs, ultrasound and measurements will be taken using consistent procedures at each visit by viewing the baseline photograph and using landmarks such as freckles and birthmarks.

Official TitleEvaluation of the Candela 1064nm:Nd:YAG Laser for Skin Tightening
NCT00585715
Principal SponsorUniversity of California, Irvine
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

22 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 40 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

CelluliteSigns and SymptomsSkin ManifestationsPathological Conditions, Signs and Symptoms

Criteria

7 inclusion criteria required to participate
Individuals, male or female, greater than 40 years of age.

Moderate skin laxity in the arms, legs, abdomen, or neck.

Subject is not overweight. Body Mass Index (B.M.I.) is ≤ 27.

Subject has Fitzpatrick skin phototype I-IV.

Show More Criteria

12 exclusion criteria prevent from participating
Subject is unable or unwilling to comply with the study requirements

Subject has pacemaker or metallic implants.

Subjects that have had liposuction or other surgical procedures (including mesotherapy) to remove fat in the treatment area during the past year.

Subject is overweight (BMI > 27).

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Laser treatment with Candela DCD cooling which produces a cryogenic fluid that cools the epidermis prior to each laser pulse. Treatment will be conducted on either the left or the right thigh, which will also be randomly determined. The contra-lateral side will not be treated and will serve as a control. The laser system to be used in is Candela GentleYAG, a 1064nm Nd:YAG laser. This arm will receive a coolant during the laser procedure.

Group II

Active Comparator
Laser treatment without cooling before each laser pulse. Treatment will be conducted on either the left or the right thigh, which will also be randomly determined. The contra-lateral side will not be treated and will serve as a control. The laser system to be used in is Candela GentleYAG, a 1064nm Nd:YAG laser. This arm will not receive a coolant during the laser procedure.

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 2 locations

Suspended

Beckman Laser Institute

Irvine, United StatesOpen Beckman Laser Institute in Google Maps
Suspended

UC Irvine Dermatology Clinical Research Center

Irvine, United States
Completed2 Study Centers